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OBJECTIVE: It is known that glucose concentrations of
peritoneal dialysis solutions are detrimental to the
peritoneal membrane. In order to determine the
effect of glucose concentration on cytokine levels of
peritoneal fluid of continuous ambulatory peritoneal
dialysis (CAPD) patients, a cross-sectional study was
performed.
Methods: Nine non-diabetic CAPD patients partici-
pated in two 8-h dwell sessions of overnight ex-
changes in consecutive days, with 1.36% and 3.86%
glucose containing peritoneal dialysis solutions
(Baxter
/Eczacıbas ¸ı). Peritoneal dialysis fluid tumor
necrosis factor (TNF)-a and interleukin (IL)-6 levels
were measured.
Results: TNF-a levels after 1.36% and 3.86% glucose
used dwells were 239 /14 pg/ml and 289 /4 pg/ml,
respectively (p/0.78). The IL-6 levels were 1069 /57
pg/ml and 1159 /63 pg/ml (p/0.81), respectively.
Conclusion: In our in vivo study we found that the
glucose concentration of the conventional lactate-
based CAPD solution has no effect on basal IL-6 and
TNF-a levels of peritoneal fluid. Further in vivo
studies with non-lactate-based CAPD solutions are
needed in order to determine the effect of glucose
concentration per se on cytokine release.
Key words: Cytokines, Peritoneal dialysis, Peritoneal
dialysis ﬂuid, Glucose concentration
Mediators of Inflammation, 13(2), 119/121 (April 2004)
Effect of glucose concentration on
peritoneal inﬂammatory
cytokines in continuous
ambulatory peritoneal dialysis
patients
Hayriye Sayarlioglu
1,CA, Cevat Topal
1,
Mehmet Sayarlioglu
2, Haluk Dulger
3, Ekrem Dogan
1
and Reha Erkoc
1
1Division of Nephrology and
2Division of
Rheumatology, Department of Internal Medicine
3Department of Biochemistry, Yuzuncu Yil University,
Tıp Faku ¨ltesi, I ˙c ¸ Hastalıkları A.D., Nefroloji B.D., 65200
Van, Turkey
CACorresponding author
Tel:  /90 532 2967570
Fax:  /90 432 2155051
E-mail: hayriyesayarlioglu@yahoo.com
Introduction
Peritoneal dialysis (PD) is established as a viable and
successful alternative to hemodialysis for end-stage
renal disease patients. However, impairment of
peritoneal membrane function remains a major factor
causing modality change in a significant number of
patients on PD. In vivo studies in long-term PD have
demonstrated diabetiform alterations of the perito-
neum.
1 These alterations are accompanied by func-
tional abnormalities, such as ultrafiltration failure or
reduced solute clearance. In addition to the induction
of pro-inflammatory and/or pro-fibrotic cytokines,
animal and in vitro studies have highlighted the
adverse effects of glucose-based peritoneal dialysis
fluid (PDF) on resident peritoneal cells.
2,3 Cytokines
known to cause inflammatory reactions are called
pro-inflammatory cytokines, such as tumor necrosis
factor (TNF)-a, interleukin (IL)-1, IL-6, IL-8, IL-12, IL-
18, granulocyte/macrophage colony-stimulating fac-
tor and interferon-g.
4 Chemical insult to peritoneal
mesothelial cells can induce the synthesis of cyto-
kines, chemokines and growth factors, and is asso-
ciated with accumulation and deposition of matrix
proteins.
5
In order to determine the effect of glucose
concentration on cytokine levels of peritoneal fluid
of continuous ambulatory peritoneal dialysis (CAPD)
patients, a cross-sectional study was performed.
Patients and methods
After informed consent was obtained, nine non-
diabetic CAPD patients participated in two 8-h dwell
sessions of overnight exchanges on consecutive days,
with 1.36% and 3.86% glucose-containing PD solu-
tions (Baxter/Eczacıbas ¸ı). The patients (three fe-
males/six males; mean age, 44.99 /17.5 years) were
stable on CAPD and had been free of peritonitis and
any inflammatory conditions for more than 8 weeks.
Dialysate samples were taken immediately after the
dwell. PDF TNF-a and IL-6 levels were measured by
using the commercial IMMULITE kits, which are a
solid-phase, two-site chemiluminescent immuno-
metric assay (Immullite, DPC, Los Angeles, CA,
USA). The Wilcoxon t-test was used to compare
cytokine levels.
Results
TNF-a levels after 1.36% and 3.86% glucose used
dwells were 239 /14 pg/ml and 289 /4 pg/ml, respec-
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119tively (p/0.78). IL-6 levels were 1069 /57 pg/ml and
1159 /63 pg/ml (p/0.81), respectively (Fig. 1, Fig. 2).
Discussion
Earlier in vitro studies underlined the cytotoxic and
inhibitory effects of conventional fluids on funda-
mental cell functions of macrophages and polymor-
phonuclear granulocytes, including their phagocytic
capacity and their ability to secrete inflammatory
cytokines.
6,7 It was known that in CAPD patients
without peritonitis spent dialysate IL-6 concentrations
are several times higher than the serum levels,
indicating local production of this cytokine in the
peritoneal cavity.
8 TNF-a levels of spent dialysate are
lower than the serum levels, but in response to
peritoneal inflammation these levels increase rapidly.
Also, dialysate TNF-a levels may be affected by the
dialysate configuration. Plum et al. reported that
application of amino acid/bicarbonate-containing
PDF resulted in significantly higher dialysate TNF
concentrations when compared with glucose/bicar-
bonate-containing solutions.
9 A limited number of in
vivo studies analyzed the effects of different glucose
concentrations on IL-6 and TNF-a release from
peritoneal or peripheral blood macrophages, mono-
cytes or mesothelial cells. Douvdevani et al. studied
the in vitro effect of dialysis fluid on the basal and
lipopolysaccharide stimulated release of IL-1b and
TNF-a by peritoneal macrophages and peripheral
blood mononuclear cells (PBMC), and the time
course and factors involved in this effect. They found
that the presence or absence of glucose had no effect
on cytokine production but pH and lactate are the
important inhibitory factors.
10
In another in vitro study Jorres et al. reported that,
while bicarbonate and 1.5% glucose-based PD solu-
tion did not inhibit cytokine release (mononuclear
leukocyte IL-6 and TNF-a release in response to
bacterial lipopolysaccharide), bicarbonate and 4.25%
glucose-based PD solution exerted /80% inhibi-
tion.
11 Cendoroglo et al. investigated the effects of
high glucose concentration, osmolarity, and heat
sterilization of PDFs on TNF-a production by PBMC
and polymorphonuclear cell (PMN) functions. They
found that high glucose concentration induced an
increase in TNF-a production by unstimulated
PBMCs, a decrease in TNF-a production by endo-
toxin-stimulated PBMCs, and an inhibition of PMN
functions. These effects were also compared for
different glucose concentrations when osmolarity
was equally adjusted with mannitol and for different
osmolarity levels when glucose was equally adjusted.
They suggested that high glucose concentration, high
osmolarity, and heat sterilization of PDF adversely
affect PBMC and PMN functions.
12
Cooker et al. reported that in CAPD patients
treatment with bicarbonate/lactate is associated with
decreased peritoneal IL-6 synthesis and decreased
vascular endothelial growth factor secretion when
compared with conventional glucose-based PDF.
13
Serre et al. reported that in non-uremic individuals
peritoneal lavage with dialysis fluid inhibited the
cytokine production (IL-1, IL-6, IL-8, TNF-a and IL-
1b), and with isotonic NaCl cells produced less
cytokines when compared with dialysis patients.
14
When compared with conventional glucose-based
PDF, human peritoneal mesothelial cells (HPMCs)
cultured with amino acid-based PDF resulted in
higher IL-6 secretion, indicative of improved syn-
thetic capacity of the cells.
15
In our in vivo study we found that the glucose
concentration of the CAPD solution has no effect on
basal IL-6 and TNF-a levels of peritoneal fluid. There
is no similar study in the literature concerning effects
of different glucose concentrations on spent dialysate
cytokine concentrations. How can these contrary in
vitro and in vivo results for the effect of glucose
concentration on unstimulated IL-6 and TNF-a levels
in spent dialysate be explained? First, in vivo results
are affected by the whole biologic milieu and may be
substantially different from the in vitro systems that
characteristically under the insult of multiple factors.
Lactate or another factor may hinder the effect of
different glucose concentrations on cytokine release;
also, a type 2 statistical error cannot be excluded.
FIG. 1. TNF-a levels after 1.36% and 3.86% glucose used
dwells for each patient.
FIG. 2. IL-6 levels after 1.36% and 3.86% glucose used dwells
for each patient.
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lactate-based PDF glucose concentration does not
seem to effect the peritoneal release of IL-6 and TNF-
a in vivo. Further in vivo studies are needed with
non-lactate-based solutions in order to determine the
effect of glucose concentration per se on peritoneal
cytokine release.
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